EMA warns against use of unproven cell therapies

Heard from FAMHP

June 2, 2020

The Committee for Advanced Therapies (CAT) of the European Medicines Agency (EMA) advises patients and citizens not to use unregulated cell therapies, which may be unsafe or ineffective.

The CAT opinion was formulated in response to individuals, companies and hospitals promoting cell therapies that are not scientifically validated as remedies for a wide range of diseases, including cancer, cardiovascular disease, autism, cerebral palsy, muscular dystrophy and loss of vision. More information.